BP000221-CYT-287: Recombinant Human Leptin (LEP) Protein, His Tag
Source: E. Coli-derived.
Purity: > 90.0% by RP-HPLC and SDS-PAGE.
Applications: Positive control for Western blot; Antibody production; Protein assay.BP000221-CYT-507: Recombinant Rabbit Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Purity: > 95.0% by reducing SDS?-PAGE and SEC-HPLC.BP000221-CYT-508: Recombinant Human Leptin (LEP) Protein
Source: E. Coli-derived.
Purity: > 98.0% by reducing SDS-PAGE and SEC-HPLC.BP000221-CYT-509: Recombinant Chicken Leptin (LEP) Protein
Source: E. Coli-derived.
Purity: > 99.0% by reducing SDS?-PAGE and SEC-HPLC.BP000221-CYT-506: Recombinant Dog Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Purity: > 95.0% by reducing SDS-PAGE and SEC-HPLC.BP000221-CYT-592: Recombinant Rat Pegylated Leptin (LEP) Protein
Source: E. Coli-derived.
Pegylated Rat Leptin is capable of stimulatng proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is only slightly lower than the non-pegylated antagonist but in vivo it has profound weight reducing effect (as compared to the non-pegylated leptin), resulting mainly from reduced food intake.
Purity > 99.0% by reducing SDS-PAGE and SEC-HPLC.BP000221-CYT-566: Recombinant Mouse Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-567: Recombinant Rat Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-702: Recombinant Human Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher.
Purity > 98.0% by Gel filtration analysis and SDS-PAGE.BP000221-CYT-703: Recombinant Ovine Leptin Antagonist Triple Mutant Pegylated
Source: E. Coli-derived.
Purity > 95.0% as determined by Gel filtration analysis and SDS-PAGE.